The Vanguard Group Discloses Position in Mural Oncology plc

The Vanguard Group, Inc. has released a disclosure under Form 8.3 related to their position in Mural Oncology plc. As of June 3, 2025, Vanguard holds interests in 772,899 ordinary shares of Mural Oncology, representing 4.48% of the company's securities. This disclosure complies with the Irish Takeover Panel Act, 1997, and updated Takeover Rules of 2022.

Vanguard's disclosure covers ownership and does not include short positions in the specified securities. No additional parties involved in the transaction are mentioned, indicating focus solely on Mural Oncology. A minimal transaction was reported: Vanguard sold 32 ordinary shares at a price of 2.63 USD per unit.

No supplemental agreements or derivatives are associated with this disclosure, and Vanguard confirms no indemnities or arrangements that could influence securities dealings.